Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Patient-centricity at the heart of innovation

Discover the patient-driven design behind YpsoDose, our wearable patch injector for large-volume biologics. Learn how human factors shaped its intuitive, comfortable, and reliable use—simplifying self-injection for patients at home.
Read more...

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.
Read more...

Automated assembly for fast-track design verification of YpsoMate platforms

Discover how Ypsomed’s innovative in-house assembly system streamlines workflows, enhances precision and slashes verification times, helping customers bring their products to market with speed and confidence.
Read more...

A fresh look at how patients interact with pen injectors

How do patients handle pen injectors, and what forces do they apply during use? How can these findings shape the design of future devices to improve comfort and usability, especially for those with dexterity challenges?
Read more...

Reduced injection time and effort for enhanced patient comfort

Discover the latest innovation from Ypsomed: the YpsoMate 2.25 autoinjector, now configurated with an 8 mm needle. Designed to enhance patient comfort and injection efficiency, this new option continues our commitment to improving patient experiences …
Read more...

First Deliveries of YpsoMate 1 mL as part of the NetZero Program

Ypsomed supplied first batches of YpsoMate 1 mL with a reduced carbon footprint as part of the NetZero Program in 2023 . This milestone is a key step in the transformation of the platform proven YpsoMate autoinjector into a zero-carbon emission …
Read more...

Clicking sounds of autoinjectors: A method to assess the audibility considering the spectrum of human hearing

To make sure people with visual and hearing impairments can use the YpsoMate autoinjectors without limitations, the devices are tested at METAS regarding the effectiveness of their acoustic signals.
Read more...

Milestones in manufacturing: Mastering UnoPen and YpsoPen success

UnoPen and YpsoPen are two of Ypsomed’s platforms developed and customized on behalf of various pharma customers for patients dependent on insulin but also GLP-1, hGH, FSH and PTH. Demand for these devices has now exceeded the total of 100 million …
Read more...
Load more